“Let me worry about that,” Saul said. He sidled over with a crablike motion, waggling his shoulders, self-mocking in that way only he could manage, and hugged her with one arm, dropping his face to her shoulder. She stroked his head.
“I hate this,” he said. “I really, really hate being like this.”
“You are very strong, Saul,” Kaye whispered into his ear.
“You’re my strength,” he said, and pushed away, rubbing his cheek like a little boy who has been kissed. “I love you more than life itself, Kaye. You know that. Don’t worry about me.”
For a moment, there was a lost, feral wildness in his eyes, cornered, nowhere left to hide. Then that passed, and his shoulders drooped and he shrugged.
“I’ll be fine. We’ll prevail, Kaye. I just have to make some calls.”
Debra Kirn was a slender woman with a broad face and a smooth bowl of thick black hair. Eurasian, she tended to be quietly authoritarian. She and Kaye got along very well, though she was prickly with Saul and most men.
Kim ran the cholera isolation lab at EcoBacter with a glove of velvet-wrapped steel. The second largest lab in EcoBacter, the isolation lab functioned at level 3, more to protect Kirn’s supersensitive mice than the workers, though cholera was no joke. She used severe combined immunodeficient, or SCID, mice, genetically shorn of an immune system, in her research.
Kim took Kaye through the outer office of the lab and offered her a cup of tea. They engaged in small talk for several minutes, watching through a pane of clear acrylic the special sterile plastic and steel containers stacked along one wall and the active mice within.
Kim was working to find an effective phage-based therapy against cholera. The SCID mice had been equipped with human intestinal tissues, which they could not reject; they thus became small human models of cholera infection. The project had cost hundreds of thousands of dollars and had produced slim results, but still, Saul kept it going.
“Nicki down in payroll says we may have three months left,” Kim said without warning, setting down her cup and smiling stiffly at Kaye. “Is that true?”
“Probably,” Kaye said. “Three or four. Unless we seal a partnership with Eliava. That would be sexy enough to bring in some more capital.”
“Shit,” Kim said. “I turned down an offer from Procter and Gamble last week.”
“I hope you didn’t burn any bridges,” Kaye said.
Kim shook her head. “I like it here, Kaye. I’d rather work with you and Saul than almost anyone else. But I’m not getting any younger, and I have some pretty ambitious work in mind.”
“So do we all,” Kaye said.
“I’m pretty close to developing a two-pronged treatment,” Kim said, walking to the acrylic panel. “I’ve got the gene connection between the endotoxins and adhesins. The cholerae attach to our little intestinal mucus cells and make them drunk. The body resists by shedding the mucus membranes. Rice-water stools. I can make a phage that carries a gene that shuts down pilin production in the cholera. If they can make toxin, they can’t make pili, and they can’t adhere to mucus cells in the intestine. We deliver capsules of phage to cholera-infected areas, voila. We can even use them in water treatment programs. Six months, Kaye. Just six more months and we could hand this over to the World Health Organization for seventy-five cents a dose. Just four hundred dollars to treat an entire water purification plant. Make a very tidy profit and save several thousand lives every month.”
“I hear you,” Kaye said.
“Why is riming everything?” Kirn asked softly, and poured herself another cup of tea.
“Your work won’t stop here. If we go under, you can take it with you. Go to another company. And take the mice. Please.”
Kirn laughed, then frowned. “That’s insanely generous of you. What about you? Are you just going to bite the bullet and sink under the debts, or declare bankruptcy and go to work for the Squibb? You could get work easily enough, Kaye, especially if you strike before the publicity dies down. But what about Saul? This company is his life.”
“We have options,” Kaye said.
Kirn drew the ends of her lips down in concern. She put her hand on Kaye’s arm. “We all know about his cycles,” she said. “Is this getting to him?”
Kaye half shuddered, half shivered at this, as if to throw off any unpleasantness. “I can’t talk about Saul, Kirn. You know that.”
Kim threw her hands up in the air. “Christ, Kaye, maybe you could use all the publicity to take the company public, get some funding. Tide us over for another year…”
Kim had very little sense of how business worked. She was atypical this way; most biotech researchers in private companies were very savvy about business. No francs, no Frankenstein s monster, she had heard one of her colleagues say. “We couldn’t convince anybody to back us for a public offering,” Kaye said. “SHEVA has nothing to do with EcoBacter, not now at any rate. And cholera is Third World stuff. It isn’t sexy, Kim.”
“It isn’t?” Kim said, and fluttered her hands in disgust. “Well, what in hell is sexy in the big old bidness world today?”
“Alliances and high profits and stock value,” Kaye said. She stood and tapped the plastic panel near one of the mouse cages. The mice inside reared up and wriggled their noses.
Kaye walked into Lab 6, where she did most of her research. She had handed off her bacteriocin studies a month ago to some postdocs in Lab 5. This lab was being used by Kirn’s assistants for the time being, but they were at a conference in Houston, and the lab had been closed, the lights turned off.
When she wasn’t working on antibiotics, her favorite subjects had been Henle 407 cultures, derived from intestinal cells; she had used them to meticulously study aspects of mammalian genomes and to locate potentially active HERV. Saul had encouraged her, perhaps foolishly; she could have focused completely on the bacteriocin research, but Saul had assured her she was a golden girl. Anything she touched would advance the company.
Now, lots of glory, but no money.
The biotech industry was unforgiving at best. Maybe she and Saul simply did not have what it took.
Kaye sat in the middle of the lab on a rolling chair that had somehow lost a wheel. She leaned to one side, hands on her knees and tears slicking her cheeks. A small and persistent voice in the back of her head told her that this could not go on. The same voice continued to warn her that she had made bad choices in her personal life, but she could not imagine how she could have done otherwise. Despite everything, Saul was not her enemy; far from being a brutal or abusive man, he was simply a victim of tragic biological imbalances. His love for her was pure enough.
What had started her tears was this treasonous inner voice that insisted that she should get out of this situation, abandon Saul, start over again; no better time. She could get work in a university lab, apply for funding for a pure research project that suited her, escape this damned and very literal rat race.
Yet Saul had been so loving, so right when she had returned from Georgia. The paper on evolution had seemed to rekindle his interest in science over profit. Then…the setbacks, the discouragement, the downward spiral. Bad Saul.
She did not want to face again what had happened eight months ago. Saul’s worst breakdown had tested her own limits. His attempted suicides — two of them — had left her exhausted, and, more than she cared to admit, embittered. She had fantasized about living with other men, calm and normal men, men closer to her own age.
Kaye had never told Saul about these wishes, these dreams; she wondered if perhaps she needed to see her own psychiatrist, but she had decided against it. Saul had spent tens of thousands of dollars on psychiatrists, had gone through five regimens of drug therapy, had once suffered complete loss of sexual function and weeks of being unable to think clearly. For him, the miracle drugs did not work.